SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________

FORM 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

March 11, 2003

SYNSORB Biotech Inc.
Commission File No. 0-29214
(Translation of registrant’s name into English)

411 – 19^th Street SE
Calgary, Alberta, Canada, T2E 6J7
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F

Form 40-F

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Act of 1934.

Yes

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b): 82- N/A

Exhibit Number

Exhibit

1.	Press release of SYNSORB Biotech Inc. dated March 11, 2003

2.	Management Discussion and Analysis

3.	Annual Financial Statements for the year ended December 31, 2002

4.	Notice of Meeting and Information Circular

5.	Form of Proxy

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 11, 2003

SYNSORB BIOTECH INC.

By: (Signed) “Bruce Kenway”
Bruce Kenway
Director

Exhibit Index

Exhibit Number

Exhibit

Page

Press release of SYNSORB Biotech Inc. dated March 11, 2003

Management Discussion and Analysis

Annual Financial Statements for the year ended December 31, 2002

Notice of Meeting and Information Circular

Form of Proxy

SECURITIES AND EXCHANGE COMMISSION

FORM 6-K

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

SIGNATURES

Exhibit Index

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

SYNSORB BIOTECH INC 6-K